University Of Bridgeport D/b/a Health Sciences Center in Bridgeport, CT - Naturopath

University Of Bridgeport D/b/a Health Sciences Center is a Naturopath based in Bridgeport, Connecticut. University Of Bridgeport D/b/a Health Sciences Center is licensed to practice in * (Not Available) (license number ) and their current practice location is 60 Lafayette St, Bridgeport, Connecticut. It can be reached at their office (for appointments etc.) via phone at (203) 576-4349.

NPI number for University Of Bridgeport D/b/a Health Sciences Center is 1477795235 and their current mailing address is 60 Lafayette St, Bridgeport, Connecticut. University Of Bridgeport D/b/a Health Sciences Center does not participate in medicare program and thus does not accept medicare assignments. The facility's NPI Number is 1477795235.

Contact Information

	University Of Bridgeport D/b/a Health Sciences Center
	60 Lafayette St, Bridgeport, CT 06604-7719
	(203) 576-4349
	(203) 576-4106

Healthcare Provider's Profile

Full Name	University Of Bridgeport D/b/a Health Sciences Center
Type	Facility
Speciality	Naturopath
Location	60 Lafayette St, Bridgeport, Connecticut
Accepts Medicare Assignments	Does not participate in Medicare Program. The facility may not accept medicare assignment.

NPI Data:

NPI Number: 1477795235
Provider Enumeration Date: 03/25/2009
Last Update Date: 04/10/2009

Medical Identifiers

Medical identifiers for University Of Bridgeport D/b/a Health Sciences Center such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1477795235	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
111N00000X	Chiropractor	(* (Not Available))	Secondary
171100000X	Acupuncturist	(* (Not Available))	Secondary
175F00000X	Naturopath	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. University Of Bridgeport D/b/a Health Sciences Center is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
University Of Bridgeport D/b/a Health Sciences Center 60 Lafayette St, Bridgeport, CT 06604-7719 Ph: (203) 576-4349	University Of Bridgeport D/b/a Health Sciences Center 60 Lafayette St, Bridgeport, CT 06604-7719 Ph: (203) 576-4349

News Archive

Pfizer and Pain Therapeutics receive FDA Complete Response Letter for resubmission of REMOXY NDA

Pfizer and Pain Therapeutics, Inc. announced that a Complete Response Letter was received from the U.S. Food and Drug Administration (FDA) on the resubmission to the new drug application (NDA) for REMOXY® (oxycodone) Extended-Release Capsules CII. Pfizer is working to evaluate the issues described in the Complete Response Letter and plans to have further discussions with FDA around them.

Speaker Pelosi remarks on benefits for children in health insurance reform

Speaker Nancy Pelosi delivered remarks at an event for the Children's Health Fund this afternoon on the West Front Lawn of the Capitol to raise awareness for the more than 21 million children who will benefit from health insurance reform.

NAFC to help meet medical needs of people in Atlanta who are without health insurance

While health care reform discussions continue in the nation's capitol, the National Association of Free Clinics is bringing help to the Atlanta area for people without health insurance who are in need of medical care.

Embryonic stem cells raise hope of cellular replacement therapy for liver failure

Embryonic stem (ES) cells, known for their capacity to proliferate indefinitely and differentiate into almost all types of cells including hepatocytes, have raised the hope of cellular replacement therapy for liver failure. There have been several protocols available for hepatic fate specification from ES cells, however, most of the protocols currently used result in low yield or purity of functional hepatocytes. Valproic acid (VPA), a histone deacetylase inhibitor, has been demonstrated to facilitate the hepatic differentiation of mesenchymal stem cells. However, little is know about whether VPA could induce the hepatic differentiation of ES cells.

Study demonstrates feasibility of a revolutionary, minimally invasive approach to introducing an electrical lead to stimulate the heart

Correcting the timing of heart contractions through cardiac resynchronization therapy can be a lifesaver for people with advanced heart failure. But the procedure, as it is done today, fails in about 15 percent of patients.

University Of Bridgeport D/b/a Health Sciences Center - in Bridgeport, CT